viernes, 23 de enero de 2009

Astrazeneca Receives Japan Approval For CFC-free Corticosteroid Inhaler For Paediatric Asthma



Creatine kinase elevation were observed surrounded next to topic who received ISENTRESS. Myopathy and rhabdomyolysis own be reported; nevertheless, the relationship of ISENTRESS to these actions be not positive. ISENTRESS should be nearly new with reserve in patients at increased stake of myopathy or rhabdomyolysis, such using patients transfer concomitant medication known to impose these provisos.


The drug have be recommended in the guidelines for Management of analysis for Pediatric Patients of Bronchial Asthma, encode forth by the Japanese Society of Pediatric Allergy and Clinical Immunology.


AstraZeneca anticipate fast use of the medication.


JCN